G6PD deficiency: Study among 256 blood donors recruited at the blood transfusion center in Niamey
Citation
Daouda Alhousseini, Mounkaila Boutchi, Maïguizo Seydou, Moumouni Sina Abdramane, Sanogo Ibrahim "G6PD deficiency: Study among 256 blood donors recruited at the blood transfusion center in Niamey", International Journal of Biotech Trends and Technology (IJBTT), V6(2): 1-4 Apr - Jun 2016, Published by Seventh Sense Research Group.
Abstract
Glucose 6-Phosphate Dehydrogenase Deficiency (G6PD) is an inherited enzymopathy which is characterized by acute or chronic hemolysis attacks triggered by oxidative stress during infections, contact with chemical, during medication or foods. In a context of nutritional anemia and/or parasitic diseases involving pregnancy or major sickle cell crises, the presence of this enzymopathy poses additional challenges to the blood transfusion. To determine the prevalence of G6PD deficiency in Niamey, we undertook to conduct a prospective study in 256 blood donors at the National Blood Transfusion Center. G6PD intra erythrocytic was determined by spectrophotometry on the hemolysate of washed red blood cells. Blood donors aged 18-65 years, having satisfied prior medical consultation and which have a greater or equal hemoglobin to 12 g/dl were selected as part of this study. The average age of donors was 32 years old. The deficit is estimated at 15.7%, including 9.7% of the total deficit to 6% partial deficit. Subjects deficient male G6PD accounted for 87.5% against 12.5% for the female sex. The average activity of G6PD was 2.9 ± 0.4 IU/g Hb in deficient subjects against 11.7 ± 0.3 IU/g Hb for the non deficient. Means Hb of normal subjects, partially and totally deficient subjects were respectively 15.3 g/dl, 14.8 g/dl and 14.3 g/dl (P = 0.7). The family donation represented 61.5% and the donor parental consanguinity rate was 21%. As G6PD deficiency was higher in the donor population, targeted screening blood bags could be considered when they are intended for certain categories of patients.
References
[1] Monchy D, Babin FX, Srey CT, Ing PN, Von Xylander S, LY V, Busch Hallen J. Deficit in G6PD: Fréquence dans un groupe d’enfants d’âge préscolaire d’une région centrale du Cambodge. Med Trop 2004; 64 : 355-358
[2] Glucose 6 phosphate dehydrogenase deficiency. WHO working group. Bull World Health Organ 1989; 67: 601- 611.
[3] Garba M, Yayé B, Boutchi M, Idi N, Alio PA, Nayama M,. L’anémie sévère per gravidique et du post partum à la maternité Issaka Gazobi: Étude prospective à propos de 207 cas sur 5 mois. Journal de la Société de Biologie Clinique, 2012; n° 016 ; 101-106
[4] Mountaga Tall. Provision in blood of the hospital somine dolo of mopti. Thèse méd. Université de Bamako-Mali. 2008
[5] Bhatgwat GP, Bapat JP. G6PD in Bahraimi Blood Donors. Bahrain Medical Bulletin, december 1987 vol.9, n°3.
[6] Fatemeh Emamghorashi, Farhang Hoshmand, Abdolrahman Mohtashamifar. Screening glucose for 6 phosphate dehydrogenase deficiency in blood donors Asian J Transfus Sci. 2010 Jan; 4(1): 31-33.
[7] Diawara A. Déficit en G6PD chez les donneurs de sang du CNTS de Bamako. Thèse pharm. Université de Bamako- Mali : 2005
[8] Olatundun Williams, Daniel Gbadero, Grace Edowhorhu, Ann Brearley, Tina Slusher, Troy C. Lund,. Glucose 6 phosphate Dehydrogenase Deficiency in Nigerien Children. PLOS ONE July 2013; 8(7): 1-8
[9] Joseph Okebe, Alfred Amambua-Ngwa, Jason Parr, Sei Nishimura, Melissa Daswani, Ebako N Takem et al. The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school children. Malaria Journal 2014, 13:148
[10] Mounkaila B, Daouda A, Garba RM, Aridouane D. Neonatal glucose-6-phosphate dehydrogenase (G6PD) deficiency in Niamey. International Journal of Biotech Trends and Technology (IJBTT) 2016; 13(1): 12-14
[11] Mounkaila Boutchi, Amadou Idé Ibrahim, Alhousseini Daouda, Sabo AM Zeinabou and Ali Touré Ibrahim. Sickle Cell Anemia and Glucose-6-phosphate dehydrogenase (G6PD) deficiency: Impact on Biological and Clinical Parameters. International Journal of Biotech Trends and Technology (IJBTT) 2016; 15(1): 13-17
[12] Shanthala Devi AM,Helen R,Vanamala A,Chaithra V,Karuna R. Screening for G6PD Deficiency in Blood Donor Population. Indian J Hematol Blood Transfus 2010 26(3):122-123
[13] Samanta S, Kumar, P, Kishore Sai SUNIL, Garewal, G, Narang, A. Donor Blood Glucose 6-Phosphate Dehydrogenase Deficiency Reduces the Efficacy of Exchange Transfusion in Neonatal Hyperbilirubinemia. Pediatrics 2009; 123(1): 96-100
[14] Mohammed K. Alabdulaali, Khaled Mr. Alayed, Abdulaziz F. Alshaikh, and Shihab A. Almashhadani. Prevalence of glucose 6 phosphate dehydrogenases deficiency and sickle cell milks among blood donors Riyadh in. Asian J Transfus Sci. 2010; 4(1): 31-33.
[15] Francis RO, Jhang JS, Pham HP, Hod EA, Zimring JC, and Spitalnik SL. Glucose 6 Dehydrogenase-Deficiencies phosphate in Transfusion Medicine: The Unknown Risks. Vox Blood. 2013; 105(4): 271-282.
[16] Brewer GJ, T AR, Kellermeyer RW. The hemolytic effect of primaquine. XII. Shortened erythrocyte life span in primaquine-sensory Negroes male in the absence of drug administration. J Lab Clin Med. 1961 58: 217-24.
Keywords
Blood donors, G6PD deficiency, hemoglobin, Niamey.